Kevan Shokat co-founded Rezo Therapeutics and is a UCSF professor and HHMI investigator whose research develops new approaches to drug difficult disease targets.
Kevan Shokat co-founded Rezo Therapeutics and is a UCSF professor and HHMI investigator whose research develops new approaches to drug difficult disease targets.
Career
Academic Founder at Rezo Therapeutics until PresentCo-founder of Rezo Therapeutics.